About this trial
The goal of this prospective multicenter cohort study is to evaluate and compare the predictive utility of the EMTRAS, REMS, and GAP scores in determining key outcomes among trauma patients admitted to participating hospitals in Iraq. The primary outcomes of interest include mortality, the need for endotracheal intubation, and length of hospitalization.
The main questions it aims to answer are:
How accurately do EMTRAS, REMS, and GAP scores predict mortality in trauma patients?
How effective are these scores in predicting the need for endotracheal intubation?
How well do these scores correlate with hospitalization duration in trauma patients?
Participants will:
Be assessed using EMTRAS, REMS, and GAP scores upon admission to the emergency department.
Have their clinical outcomes, including survival, intubation requirements, and length of hospital stay, monitored throughout their hospitalization.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients presenting to the emergency department with trauma.
Patients or their legal guardians must provide informed consent to participate in the study.
Admission within 12 hours of injury.
Disqualifiers
Patients with incomplete clinical data or those discharged before scoring can be performed.
Pregnant patients (due to specific physiological considerations not accounted for by the scoring system).
Patients who died before arrival or were declared dead on arrival.
Patients who refuse participation or for whom informed consent cannot be obtained.
Trial population
The study population will consist of adult trauma patients (≥16 years) admitted to the emergency departments of participating tertiary hospitals in Iraq. Eligible patients will include those with blunt or penetrating trauma who present within 12 hours of injury. Patients will be assessed using EMTRAS, REMS, and GAP scores at admission, with outcomes monitored until discharge or in-hospital death.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Accuracy Assessment of EMTRAS, REMS, and GAP Scores in Predicting In-Hospital Mortality
This outcome evaluates the ability of EMTRAS (range 0-12), REMS (range 0-26), and GAP (range 3-24) to predict in-hospital mortality among trauma patients. Higher EMTRAS and REMS scores, and lower GAP scores, are expected to correlate with increased mortality risk.
Secondary outcomes
Accuracy Assessment of EMTRAS, REMS, and GAP Scores in Predicting the Need for Endotracheal Intubation
This outcome evaluates the predictive performance of EMTRAS (range 0-12), REMS (range 0-26), and GAP (range 3-24) in identifying trauma patients requiring endotracheal intubation during hospitalization. Higher EMTRAS and REMS scores, and lower GAP scores, are expected to be associated with an increased likelihood of intubation.
Accuracy Assessment of EMTRAS, REMS, and GAP Scores in Predicting Length of Hospitalization
This outcome assesses the ability of EMTRAS (range 0-12), REMS (range 0-26), and GAP (range 3-24) to predict hospitalization duration. Patients with lower severity scores (low EMTRAS/REMS or high GAP) are expected to have shorter hospital stays, while those with higher severity scores are likely to require prolonged hospitalization.
Accuracy Assessment of EMTRAS, REMS, and GAP Scores in Predicting In-Hospital Morbidity
This outcome evaluates the incidence and types of complications (morbidity) experienced by trauma patients, as predicted by EMTRAS (0-12), REMS (0-26), and GAP (3-24) scores. Higher EMTRAS and REMS values, and lower GAP scores, are expected to correlate with increased morbidity, including respiratory complications, infections, prolonged mechanical ventilation, and other trauma-related adverse events.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.